Association of Arterial Stiffness with Chronic Kidney Disease: A Systematic Review

Angela L Beros1, John D Sluyter1, Robert Scragg1

  • 1School of Population Health, University of Auckland, Auckland, New Zealand.

PubMed

Insights

Arterial stiffness may predict the onset and rapid decline of chronic kidney disease (CKD). However, its role in CKD progression and whether kidney function predicts arterial stiffness requires further investigation.

Area of Science:

  • Cardiovascular Health
  • Nephrology
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) often progresses undetected until significant kidney function is lost.
  • Arterial stiffness is a potential risk factor for CKD, with a possible bidirectional relationship.
  • Understanding the temporal link between arterial stiffness and CKD is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To systematically review cohort studies examining the relationship between arterial stiffness and CKD.
  • To ascertain if arterial stiffness predicts the development, progression, or rapid decline of kidney function.
  • To determine if reduced kidney function predicts future arterial stiffness.

Main Methods:

  • A systematic review of MEDLINE and Embase databases up to October 2023.
  • Included studies investigated arterial stiffness (estimated by pulse wave velocity) as a predictor of CKD.
  • Qualitative summary of study characteristics and outcomes; review protocol registered with PROSPERO.

Main Results:

  • Of 17 studies, 13 found arterial stiffness predicted incident CKD.
  • Six of 10 studies controlling for risk factors showed a positive association.
  • Arterial stiffness predicted CKD progression in 8/17 studies and rapid kidney decline in 5/8 studies; one study suggested kidney function predicts arterial stiffness.

Conclusions:

  • Arterial stiffness appears to be a predictor of incident CKD and rapid kidney function decline.
  • The association between arterial stiffness and CKD progression remains uncertain.
  • Further longitudinal research is needed to clarify the predictive role of kidney function on arterial stiffness.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
512
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
522
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
527